Virtual Reality Glasses and Stress Ball on Distress and Pain Arteriovenous Fistula Cannulation
Launched by ISTANBUL SABAHATTIN ZAIM UNIVERSITY · Apr 2, 2025
Trial Information
Current as of June 08, 2025
Completed
Keywords
ClinConnect Summary
Beginning 1-2 minute before the start of the procedure, the patients will be watched (5 minutes) with an android mobile phone inserted into the Cardboard Super Flex Binoculars Glasses.
A stress ball will be applied to the patient 1-2 minutes before the start of the procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be over 18 years old,
- • Be able to speak and understand Turkish,
- • Have the cognitive ability to answer the data collection tools,
- • Be willing to participate in the study,
- • Participate in a hemodialysis program three days a week,
- Exclusion Criteria:
- • Having a communication problem (hearing, language, understanding, etc.),
- • Having a psychiatric diagnosis (To be checked from medical records),
- • Having failed AVF cannulation at the first attempt,
- • Having any signs of infection such as redness, swelling, open wound in the area where the procedure will be performed,
- • Having used a sedative within the last 8 hours,
- • Having used any painkillers before the procedure on the same day,
About Istanbul Sabahattin Zaim University
Istanbul Sabahattin Zaim University is a prestigious educational institution dedicated to advancing research and innovation in various fields, including health sciences. The university actively engages in clinical trials to contribute to the development of effective medical treatments and interventions. With a focus on interdisciplinary collaboration, Istanbul Sabahattin Zaim University fosters an environment that promotes rigorous scientific inquiry and ethical standards in clinical research. Through its commitment to excellence in education and research, the university aims to enhance healthcare outcomes and support the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Küçükçekmece, İstanbul, Turkey
Patients applied
Trial Officials
Zülfünaz Özer
Principal Investigator
İstanbul Sabahattin Zaim Üniversitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported